Literature DB >> 9754112

Sister Mary Joseph nodule from metastatic renal cell carcinoma.

P Chen1, M R Middlebrook, S M Goldman, C M Sandler.   

Abstract

Metastatic lesions of the umbilicus are more common than primary malignancies and are commonly referred to as Sister Mary Joseph nodules. Most arise from the stomach or the female genital tract. We describe an unusual case of renal cell carcinoma with peritoneal implants producing a Sister Mary Joseph nodule diagnosed by CT. To our knowledge, no report of a urinary tract malignancy with umbilical involvement has been described in the radiological literature.

Entities:  

Mesh:

Year:  1998        PMID: 9754112     DOI: 10.1097/00004728-199809000-00017

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  5 in total

1.  Synchronous primary tumors of the kidney and the ovaries: Imaging findings.

Authors:  Athina C Tsili; Areti Charisiadi; George Koliopoulos; Sevasti Kamina; Michalis Doukas; Evagellos Paraskevaidis; Konstantine Tsampoulas
Journal:  J Radiol Case Rep       Date:  2008-11-01

2.  Umbilical metastasis from breast cancer related with tumor marker elevation.

Authors:  Yoriko Murata; Yasuhiro Ogawa; Yoko Yamawaki; Shino Kohsaki; Kei Kubota; Akihiko Nishioka; Shoji Yoshida; Naoshige Tochika
Journal:  Radiat Med       Date:  2006-01

3.  Umbilical metastasis as primary manifestation of cancer: a small series and review of the literature.

Authors:  Kyriakos Psarras; Nikolaos Symeonidis; Minas Baltatzis; Athanasios Notopoulos; Christina Nikolaidou
Journal:  J Clin Diagn Res       Date:  2014-10-20

4.  Umbilical Nodule Metastasis from Unknown Primary: Diagnostic and Therapeutic Dilemma.

Authors:  Sweety Gupta; Gaurav Sharma; Nidhi Sharma; Shreyosi Mandal; Amit Gupta; Manoj Gupta
Journal:  Surg J (N Y)       Date:  2022-06-30

5.  Umbilical metastases: current viewpoint.

Authors:  Raimondo Gabriele; Marco Conte; Federico Egidi; Mario Borghese
Journal:  World J Surg Oncol       Date:  2005-02-21       Impact factor: 2.754

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.